 | Up a level |
Number of items: 1.
Wolf, J., Heist, R., Kim, T. M., Nishio, M., Dooms, C., Kanthala, R. R., Leo, E., Giorgetti, E., Wang, Y., Mardjuadi, F. I. and Cortot, A. (2022). Efficacy and safety of capmatinib plus spartalizumab in treatment-naive patients with advanced NSCLC harboring MET exon 14 skipping mutation. Ann. Oncol., 33 (7). S. S1007 - 2. AMSTERDAM: ELSEVIER. ISSN 1569-8041